Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Sirona investors only have hope left

<< Previous

Bullboard Posts

Next >>

Comment by Ticklel1ston Nov 04, 2021 7:07pm

246 Views

Post# 34089480

RE:RE:Sirona investors only have hope left

No matter how the past has played or not played out, changing the dog and pony trainer when we are about to open a real 3 ring circus of mega deals and the dog and pony trainer is going to be the ring master might not be a good idea...unless we get 3 rings of zany circus clowns...never thought of that?

<< Previous

Bullboard Posts

Next >>

Three micro-cap stocks on an upswing worth riding